CoChat

Signaling through Ras Is Essential for retOncogene-induced Cell Differentiation in PC12 Cells

Open access
Califano, Daniela, Rizzo, Claudia, D'Alessio, Amelia, Colucci-D'Amato, G.Luca, Calı̀, Gaetano, Bartoli, Paola Cannada, Santelli, Giovanni, Vecchio, Giancarlo, de Franciscis, Vittorio · 2000 · Journal of Biological Chemistry

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Abstract

Specific germline mutations of the receptor tyrosine kinase, Ret, predispose to multiple endocrine neoplasia types 2A and 2B and familial medullary thyroid carcinoma. The mechanisms by which different Ret isoforms (Ret-2A and Ret-2B) cause distinct neoplastic diseases remain largely unknown. On the other hand, forced expression of these mutated versions of Ret induces the rat pheochromocytoma cell line, PC12, to differentiate. Here we used an inducible vector encoding a dominant-negative Ras (Ras p21(N17)) to investigate the contributions of the Ras pathway to the phenotype induced in PC12 cells by the expression of either Ret-2A or Ret-2B mutants. We show that the Ret-induced molecular and morphological changes are both mediated by Ras-dependent pathways. However, even though inhibition of Ras activity was sufficient to revert Ret-induced differentiation, the kinetics of morphological reversion of the Ret-2B- was more rapid than the Ret-2A-transfected cells. Further, we show that in Ret-transfected cells the suc1-associated neurotrophic factor-induced tyrosine phosphorylation target, SNT, is chronically phosphorylated in tyrosine residues, and associates with the Sos substrate. These results indicate the activation of the Ras cascade as an essential pathway triggered by the chronic active Ret mutants in PC12 cells. Moreover, our data indicate SNT as a substrate for both Ret mutants, which might mediate the activation of this cascade.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m905866199

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG. 1 Ras expression induced by dexamethasone in PC12/ MEN2 N17 cells . Northern blot analysis of total cellular RNA (20 m g/ lane) obtained from PC12 and PC12 variant cells as indicated: parental PC12, PC12/MEN2A-cl.3 ( MEN2A ), PC12/MEN2A N17 ( MEN2A N17 ), PC12/MEN2B-cl.7 ( MEN2B ), and PC12/MEN2B N17 ( MEN2B N17 ). Cells were treated for 6 h either with vehicle ( 2 ) or with dexamethasone (0.5 m M) ( 1 ), as indicated ( DEX ). Filters were hybridized with a ras probe and equal gel loading was confirmed by the hybridization of the same filter with a ribosomal 18 S probe. The relative amounts of Ret protein in all cell lines utilized were determined by Western blot with anti-Ret antibodies and normalized with anti-tubulin antibodies. The amount of Ret in PC12/MEN2A-cl.3 was arbitrarily taken 5 1. The resulting relative amounts were: PC12/MEN2A-cl.3 5 1; PC12/MEN2A N17 -R1 5 1.3; PC12/MEN2B-cl.7 5 1.1; PC12/MEN2B N17 -R2 5 1.1; PC12 parental 5 undetectable; PC12/MEN2A-pool 5 0.5.
FIG. 1 Ras expression induced by dexamethasone in PC12/ MEN2 N17 cells . Northern blot analysis of total cellular RNA (20 m g/ lane) obtained from PC12 and PC12 variant cells as indicated: parental PC12, PC12/MEN2A-cl.3 ( MEN2A ), PC12/MEN2A N17 ( MEN2A N17 ), PC12/MEN2B-cl.7 ( MEN2B ), and PC12/MEN2B N17 ( MEN2B N17 ). Cells were treated for 6 h either with vehicle ( 2 ) or with dexamethasone (0.5 m M) ( 1 ), as indicated ( DEX ). Filters were hybridized with a ras probe and equal gel loading was confirmed by the hybridization of the same filter with a ribosomal 18 S probe. The relative amounts of Ret protein in all cell lines utilized were determined by Western blot with anti-Ret antibodies and normalized with anti-tubulin antibodies. The amount of Ret in PC12/MEN2A-cl.3 was arbitrarily taken 5 1. The resulting relative amounts were: PC12/MEN2A-cl.3 5 1; PC12/MEN2A N17 -R1 5 1.3; PC12/MEN2B-cl.7 5 1.1; PC12/MEN2B N17 -R2 5 1.1; PC12 parental 5 undetectable; PC12/MEN2A-pool 5 0.5.CC-BY · From the PDF
FIG. 2 Ras is required for expression of Krox-24 and vgf genes and for ERK kinase activity. A , Northern blot analysis of total cellular RNA (20 m g/lane) obtained from PC12 and PC12 variant cells as indicated: parental PC12, either untreated or stimulated for 5 h with NGF (100 ng/ml) as indicated; PC12/MEN2A-cl.3 ( MEN2A ); PC12/MEN2A N17 -cl.R1 ( MEN2A N17 ); PC12/MEN2B-cl.7 ( MEN2B ); PC12/MEN2B N17 -cl.R2 ( MEN2B N17 ) were treated for 6 h either with vehicle ( 2 ) or with dexamethasone (0.5 m M) ( 1 ), as indicated ( DEX ). The same filters were hybridized with either a Krox-24 -specific or vgf -specific probe as indicated, and equal gel loading was confirmed with a ribosomal 18 S probe. B , the cells and the treatment were the same as in A (except for NGF stimulation that lasted for 10 min). The cell lysates were immunoprecipitated with anti-ERK-1 antibody and assayed for kinase activity as described under 'Experimental Procedures.' In each experiment we verified that the same amounts of ERK were used in the kinase assay. Proteins from each of the immunoprecipitates were separated on 11% SDS-PAGE and immunoblotted with the same anti-ERK-1 antibody. Immunoblots confirmed that the same amount of ERK was used in each kinase assay (data not shown). The results shown were typical and representative of two independent experiments. C , PC12 cells were transfected with p Krox-24 -CAT (2 m g) together with pRet9 C634Y (0.6 m g) or pRet9 M918T (0.6 m g). Where indicated, cells were also cotransfected with increasing amount of the pZipN17 expressing the Ras p21 N17 mutant. The inhibition, calculated as the difference between the CAT activity in the absence and in the presence of pZipN17, is plotted as percentage relative to the induction observed in the absence of pZipN17. Results were from a representative experiment, and they were confirmed in two independent experiments each performed in duplicate. D , PC12 variant cells were transfected with p vgf -CAT (2 m g) together with either the pBabe Ha-Ras or the pBabe vector (8 m g), as indicated. Where indicated, dexamethasone was added 5 h after transfection. Results are expressed as percentage of conversion to acetylated [ 14 C]chloramphenicol.
FIG. 2 Ras is required for expression of Krox-24 and vgf genes and for ERK kinase activity. A , Northern blot analysis of total cellular RNA (20 m g/lane) obtained from PC12 and PC12 variant cells as indicated: parental PC12, either untreated or stimulated for 5 h with NGF (100 ng/ml) as indicated; PC12/MEN2A-cl.3 ( MEN2A ); PC12/MEN2A N17 -cl.R1 ( MEN2A N17 ); PC12/MEN2B-cl.7 ( MEN2B ); PC12/MEN2B N17 -cl.R2 ( MEN2B N17 ) were treated for 6 h either with vehicle ( 2 ) or with dexamethasone (0.5 m M) ( 1 ), as indicated ( DEX ). The same filters were hybridized with either a Krox-24 -specific or vgf -specific probe as indicated, and equal gel loading was confirmed with a ribosomal 18 S probe. B , the cells and the treatment were the same as in A (except for NGF stimulation that lasted for 10 min). The cell lysates were immunoprecipitated with anti-ERK-1 antibody and assayed for kinase activity as described under 'Experimental Procedures.' In each experiment we verified that the same amounts of ERK were used in the kinase assay. Proteins from each of the immunoprecipitates were separated on 11% SDS-PAGE and immunoblotted with the same anti-ERK-1 antibody. Immunoblots confirmed that the same amount of ERK was used in each kinase assay (data not shown). The results shown were typical and representative of two independent experiments. C , PC12 cells were transfected with p Krox-24 -CAT (2 m g) together with pRet9 C634Y (0.6 m g) or pRet9 M918T (0.6 m g). Where indicated, cells were also cotransfected with increasing amount of the pZipN17 expressing the Ras p21 N17 mutant. The inhibition, calculated as the difference between the CAT activity in the absence and in the presence of pZipN17, is plotted as percentage relative to the induction observed in the absence of pZipN17. Results were from a representative experiment, and they were confirmed in two independent experiments each performed in duplicate. D , PC12 variant cells were transfected with p vgf -CAT (2 m g) together with either the pBabe Ha-Ras or the pBabe vector (8 m g), as indicated. Where indicated, dexamethasone was added 5 h after transfection. Results are expressed as percentage of conversion to acetylated [ 14 C]chloramphenicol.CC-BY · From the PDF
FIG. 3 Reversion of the PC12/MEN2 cell morphology upon treatment with 2-mercaptoethanol. A , phase contrast photomicrograph of PC12, PC12/MEN2A, and PC12/MEN2B cells. PC12, PC12/MEN2A, and PC12/MEN2B cells were grown for 11 days either in the absence ( upper panels ) or presence of 2-mercaptoehanol (500 m M) ( lower panels ) as indicated. The microphotographs represent three independent experiments. The same results were observed when independent cell clones were analyzed for each cell line. B , PC12, PC12/MEN2A or PC12/MEN2B cells were grown on glass coverslips in absence ( upper panels ) or in presence of 2-mercaptoethanol (500 m M) for 8 days ( lower panels ). Cells were fixed and stained with Hoechst 33258. Phase contrast microphotograph ( upper panels ) and Hoechst staining ( lower panels ) are shown. C , cells were grown as in A , picked up, trypsinized, and plated on glass coverslips. 24 h later, cells were fixed and stained with phalloidin. PC12 round cells were from random fields ( left panels ), PC12/MEN2A were either from random fields (untreated) or from aggregates ( middle panels ), and PC12/MEN2B flat cells were from random fields ( right panels ). The figure is representative of at least three fields for each cell line and confirmed in three independent experiments. D , expression and phosphorylation of Ret after 2-mercaptoethanol treatment. PC12/MEN2A and PC12/MEN2B cells were grown either in absence or in presence of 2-mercaptoethanol (500 m M) for 11 days as indicated. Proteins from each lysate from the designated cells (2 mg) were immunoprecipitated with anti-Ret antibodies, separated on SDS-PAGE, and immunoblotted with either anti-Ret antibody or anti-phosphotyrosine antibody, as indicated.
FIG. 3 Reversion of the PC12/MEN2 cell morphology upon treatment with 2-mercaptoethanol. A , phase contrast photomicrograph of PC12, PC12/MEN2A, and PC12/MEN2B cells. PC12, PC12/MEN2A, and PC12/MEN2B cells were grown for 11 days either in the absence ( upper panels ) or presence of 2-mercaptoehanol (500 m M) ( lower panels ) as indicated. The microphotographs represent three independent experiments. The same results were observed when independent cell clones were analyzed for each cell line. B , PC12, PC12/MEN2A or PC12/MEN2B cells were grown on glass coverslips in absence ( upper panels ) or in presence of 2-mercaptoethanol (500 m M) for 8 days ( lower panels ). Cells were fixed and stained with Hoechst 33258. Phase contrast microphotograph ( upper panels ) and Hoechst staining ( lower panels ) are shown. C , cells were grown as in A , picked up, trypsinized, and plated on glass coverslips. 24 h later, cells were fixed and stained with phalloidin. PC12 round cells were from random fields ( left panels ), PC12/MEN2A were either from random fields (untreated) or from aggregates ( middle panels ), and PC12/MEN2B flat cells were from random fields ( right panels ). The figure is representative of at least three fields for each cell line and confirmed in three independent experiments. D , expression and phosphorylation of Ret after 2-mercaptoethanol treatment. PC12/MEN2A and PC12/MEN2B cells were grown either in absence or in presence of 2-mercaptoethanol (500 m M) for 11 days as indicated. Proteins from each lysate from the designated cells (2 mg) were immunoprecipitated with anti-Ret antibodies, separated on SDS-PAGE, and immunoblotted with either anti-Ret antibody or anti-phosphotyrosine antibody, as indicated.CC-BY · From the PDF
FIG. 4 Reversion of PC12/MEN2 N17 cells morphology induced by the expression of Ras p21 N17 . A , phase contrast microphotograph of PC12/MEN2A N17 -R1 and MEN2B N17 -R2 cells. PC12/MEN2A N17 -R1 and PC12/MEN2B N17 -R2 cells were grown up to 11 days either in the absence (vehicle) or in presence of dexamethasone (0.5 m M) as indicated. The microphotographs are representative of three independent experiments. B , cells were grown as in A , picked up, trypsinized, and plated on coverslips. 24 h later, cells were fixed and stained with phalloidin. PC12/MEN2A N17 ( MEN2A N17 ) and PC12/MEN2B N17 ( MEN2B N17 ) cells were either from random fields (vehicle) or aggregates (dexamethasone). The figure is representative of at least three fields for each cell line, and confirmed in three independent experiments.
FIG. 4 Reversion of PC12/MEN2 N17 cells morphology induced by the expression of Ras p21 N17 . A , phase contrast microphotograph of PC12/MEN2A N17 -R1 and MEN2B N17 -R2 cells. PC12/MEN2A N17 -R1 and PC12/MEN2B N17 -R2 cells were grown up to 11 days either in the absence (vehicle) or in presence of dexamethasone (0.5 m M) as indicated. The microphotographs are representative of three independent experiments. B , cells were grown as in A , picked up, trypsinized, and plated on coverslips. 24 h later, cells were fixed and stained with phalloidin. PC12/MEN2A N17 ( MEN2A N17 ) and PC12/MEN2B N17 ( MEN2B N17 ) cells were either from random fields (vehicle) or aggregates (dexamethasone). The figure is representative of at least three fields for each cell line, and confirmed in three independent experiments.CC-BY · From the PDF
FIG. 5 Ret-2A and Ret-2B expression induce tyrosine phosphorylation of FRS2/SNT in PC12. A , cell lysates were from the following cells: parental PC12, either left untreated or stimulated for 10 min with NGF (100 ng/ml) as indicated; PC12/MEN2A-cl.3 ( MEN2A ); PC12/MEN2A N17 -cl.R1 ( MEN2A N17 ); PC12/MEN2B-cl.7 ( MEN2B ); PC12/MEN2B N17 -cl.R2 ( MEN2B N17 ). Cells were treated for 6 h either with vehicle ( 2 ) or with dexamethasone (0.5 m M) ( 1 ), as indicated ( DEX ). Cell lysates were incubated with p13 suc1 -agarose, eluted, and analyzed: anti-phosphotyrosine immunoblot of p13 suc1 -agarose captured proteins ( upper panel ) and anti-Sos1 immunoblot of p13 suc1 -agarose captured proteins ( lower panel ). The results are representative of three independent experiments. Molecular mass markers are indicated in kilodaltons. The position of SNT is also indicated. B , cell lysates from PC12, PC12/wt, PC12/MEN2A, and PC12/MEN2B were immunoprecipitated ( IP ) with anti-Ret ( left panel ) or anti-FRS-2 antibodies ( right panel ), separated by SDS-PAGE and immunoblotted ( IB ) with anti-Ret, anti-FRS2, or anti-phosphotyrosine antibodies, as indicated.
FIG. 5 Ret-2A and Ret-2B expression induce tyrosine phosphorylation of FRS2/SNT in PC12. A , cell lysates were from the following cells: parental PC12, either left untreated or stimulated for 10 min with NGF (100 ng/ml) as indicated; PC12/MEN2A-cl.3 ( MEN2A ); PC12/MEN2A N17 -cl.R1 ( MEN2A N17 ); PC12/MEN2B-cl.7 ( MEN2B ); PC12/MEN2B N17 -cl.R2 ( MEN2B N17 ). Cells were treated for 6 h either with vehicle ( 2 ) or with dexamethasone (0.5 m M) ( 1 ), as indicated ( DEX ). Cell lysates were incubated with p13 suc1 -agarose, eluted, and analyzed: anti-phosphotyrosine immunoblot of p13 suc1 -agarose captured proteins ( upper panel ) and anti-Sos1 immunoblot of p13 suc1 -agarose captured proteins ( lower panel ). The results are representative of three independent experiments. Molecular mass markers are indicated in kilodaltons. The position of SNT is also indicated. B , cell lysates from PC12, PC12/wt, PC12/MEN2A, and PC12/MEN2B were immunoprecipitated ( IP ) with anti-Ret ( left panel ) or anti-FRS-2 antibodies ( right panel ), separated by SDS-PAGE and immunoblotted ( IB ) with anti-Ret, anti-FRS2, or anti-phosphotyrosine antibodies, as indicated.CC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 39 references

Research works printed but not linked: 12

  1. Tsuzuki, T., Takahashi, M., Asai, M., Iwashita, T., Matsuyama, M., and Asai, J. (1995) Oncogene 10, 191-198
  2. Colucci-D' Amato, G. L., D' Alessio, A., Filliatreau, G., Florio, T., Di Giamberardino, L., Chiappetta, G., Vecchio, G., Fusco, A., Santoro, M., and de Franciscis, V. (1996) Cell Growth Diff. 7, 1081-1086
  3. Borrello, M. G., Smith, D. P., Pasini, B., Bongarzone, I., Greco, A., Lorenzo, M. J., Arighi, E., Miranda, C., Eng, C., Alberti, L., Bocciardi, R., Mondellini, P., Scopsi, L., Romeo, G., Ponder, B. A. J., and Pierotti, M. A. (1995) Oncogene 11, 2419 -2417
  4. D' Arcangelo, G., and Halegoua, S. (1993) Mol. Cell. Biol. 13, 3146 -3155
  5. Califano, D., Monaco, C., De Vita, G., D'Alessio, A., Dathan, N. A., Possenti, R., Vecchio, G., Fusco, A., Santoro, M., and de Franciscis, V. (1995) Oncogene 11, 107-112
  6. D'Alessio, A., De Vita, G., Cali, G., Nitsch, L., Fusco, A., Vecchio, G., Santelli, G., Santoro, M., and de Franciscis, V. (1995) Cell Growth Diff. 6, 1387-1394
  7. Tahira, T., Ishizaka, Y., Itoh, F., Sugimura, T., and Nagao, M. (1990) Oncogene 5, 97-102
  8. van Weering, D. H., Medema, J. P., van Puijenbroek, A., Burgering, B. M., Baas, P. D., and Bos, J. L. (1995) Oncogene 11, 2207-2214
  9. Rabin, S. J., Cleghon, V., and Kaplan, D. R. (1993) Mol. Cell. Biol. 13, 2203-2213
  10. Wang, J. K., Xu, H., Li, H. C., and Goldfarb, M. (1996) Oncogene 13, 721-729
  11. Feig, L. A., and Cooper, G. M. (1988) Mol. Cell. Biol. 8, 2472-2478
  12. Szeberenyi, J., Cai, H., and Cooper, G. M. (1990) Mol. Cell. Biol. 10, 5324 -5332

Cited by

Metadata

Authors
Califano, D., Rizzo, C., D'Alessio, A., Colucci-D'Amato, G. L., Calı̀, G., Bartoli, P. C., Santelli, G., Vecchio, G., & de Franciscis, V.
Affiliations
  • Institute for Experimental Endocrinology and Oncology (IT)
  • Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" (IT)
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2000-06
Volume
275
Issue
25
Pages
19297-19305
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2045078390
Cited by
67
References
39
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2022: 2 · 2021: 1 · 2019: 2 · 2018: 1 · 2017: 4 · 2016: 1 · 2015: 6 · 2014: 4 · 2013: 3 · 2012: 3
FWCI
1.81
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
  • INFM-OAR (INFN Catania) (submittedVersion, cc-by)
Funders
  • Fondazione Telethon
  • Consiglio Nazionale delle Ricerche
  • Associazione Italiana per la Ricerca sul Cancro
  • National Institutes of Health (MD 20892)
  • Fogarty International Center
  • Center for Advanced Study, University of Illinois at Urbana-Champaign
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
  • Health Sciences › Medicine › Clinical Neurology › Neurofibromatosis and Schwannoma Cases
Keywords
RET receptor tyrosine kinase, Ras signaling, PC12 cells, neuronal differentiation, dominant negative Ras, multiple endocrine neoplasia type 2, medullary thyroid carcinoma, SO, tyrosine phosphorylation
MeSH terms
Animals, Cell Differentiation, Membrane Proteins, Neurons, Oncogenes, Phosphoproteins, Phosphorylation, Proto-Oncogene Proteins, Tyrosine, Signal Transduction, Oncogene Protein p21(ras), PC12 Cells, Receptor Protein-Tyrosine Kinases, Drosophila Proteins, Adaptor Proteins, Signal Transducing, Proto-Oncogene Proteins c-ret, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.